Treatment of ribavirin/interferon-induced anemia with erythropoietin in patients with hepatitis C
- 1 May 2002
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 35 (5), 1281-1282
- https://doi.org/10.1053/jhep.2002.32529
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfectionThe Lancet, 2001
- Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: Role of membrane oxidative damageHepatology, 2000
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis CNew England Journal of Medicine, 1998
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusThe Lancet, 1998